Aeglea BioTherapeutics Inc. (AGLE) rose 11.63% or 1.13 to $10.85. It is nearly 141827 shares traded, which is 46.15% compare to the average total volume 307300. The market cap of AGLE is $237.17 million. The year to date change is 80.67%. The 52 week price range is from $2.81 to $11.35. Price of AGLE have changed -8.04% during last week. It have changed 22.42% over last month, 52.35% over last 3 months, 130.88% over last 6 months and 119.41% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.60. It is -11.52% below current price. The 200-day Moving Averages for AGLE is 6.31. It is -41.84% below current price. The 52-week High is 11.35. It is 4.61% from the current price. The 52-week Low is 2.81. It is -74.10% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 0.35 on 2018-04-30. Short % to float is 0.49%. There are some statistics of AGLE. It is has market cap $237.17 million. The share outstanding is 21.86 million. The average volume is 307300. The revenue is 2.74M. The percent of top 15 Institution holding is 57.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -57.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -52.42%.